BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23892094)

  • 1. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR; Boyatzis A; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-2-Oxothiazolidine-4-carboxylate reverses glutathione oxidation and delays fatigue of skeletal muscle in vitro.
    Ferreira LF; Gilliam LA; Reid MB
    J Appl Physiol (1985); 2009 Jul; 107(1):211-6. PubMed ID: 19407260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis.
    Terrill JR; Radley-Crabb HG; Grounds MD; Arthur PG
    Neuromuscul Disord; 2012 May; 22(5):427-34. PubMed ID: 22206641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
    Terrill JR; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualizing and quantifying oxidized protein thiols in tissue sections: a comparison of dystrophic mdx and normal skeletal mouse muscles.
    Iwasaki T; Terrill J; Shavlakadze T; Grounds MD; Arthur PG
    Free Radic Biol Med; 2013 Dec; 65():1408-1416. PubMed ID: 24095851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
    Mok E; Constantin B; Favreau F; Neveux N; Magaud C; Delwail A; Hankard R
    Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
    Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
    Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to taurine treatment.
    Butchart LC; Terrill JR; Rossetti G; White R; Filipovska A; Grounds MD
    Int J Biochem Cell Biol; 2018 Jun; 99():52-63. PubMed ID: 29578051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury.
    Lee S; Moon SO; Kim W; Sung MJ; Kim DH; Kang KP; Jang YB; Lee JE; Jang KY; Lee SY; Park SK
    Nephrol Dial Transplant; 2006 Aug; 21(8):2085-95. PubMed ID: 16705027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the
    Terrill JR; Huchet C; Le Guiner C; Lafoux A; Caudal D; Tulangekar A; Bryson-Richardson RJ; Sztal TE; Grounds MD; Arthur PG
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice.
    Dizdar N; Kullman A; Kågedal B
    Cancer Chemother Pharmacol; 2000; 45(3):192-8. PubMed ID: 10663636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.
    Terrill JR; Radley-Crabb HG; Iwasaki T; Lemckert FA; Arthur PG; Grounds MD
    FEBS J; 2013 Sep; 280(17):4149-64. PubMed ID: 23332128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice.
    Williams IA; Allen DG
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1969-77. PubMed ID: 17573457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells.
    Moraes LH; Bollineli RC; Mizobuti DS; Silveira Ldos R; Marques MJ; Minatel E
    Redox Rep; 2015 May; 20(3):109-15. PubMed ID: 25361473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine.
    Banks MF; Stipanuk MH
    J Nutr; 1994 Mar; 124(3):378-87. PubMed ID: 8120657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.